peter carroll

peter carroll

University of California, San Francisco

H-index: 159

North America-United States

About peter carroll

peter carroll, With an exceptional h-index of 159 and a recent h-index of 89 (since 2020), a distinguished researcher at University of California, San Francisco, specializes in the field of oncology, prostate cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

Transcriptomic heterogeneity of expansile cribriform and other Gleason Pattern 4 prostate cancer subtypes

PD13-01 DETERMINING LONG-TERM PROSTATE CANCER OUTCOMES FOR ACTIVE SURVEILLANCE PATIENTS WITHOUT EARLY DISEASE PROGRESSION: WHEN TO SLOW OR STOP SURVEILLANCE

First-in-human evaluation of a prostate-specific membrane antigen–targeted near-infrared fluorescent small molecule for fluorescence-based identification of prostate cancer in …

Shed Trop2 drives prostate cancer progression and Trop2 is a novel tissue prognostic biomarker and a candidate urinary marker for prostate cancer

MP34-01 BASELINE PROSTATE-SPECIFIC ANTIGEN SCREENING VALUES IN TRANSGENDER WOMEN ON GENDER-AFFIRMING HORMONE THERAPY: A NATIONAL COHORT STUDY

The impact of genomic biomarkers on a clinical risk prediction model for upgrading/upstaging among men with favorable‐risk prostate cancer

RE: Clinical practice guidelines

PD26-12 PERSISTENT NEED FOR SYSTEMATIC BIOPSY FOR THOSE ON ACTIVE SURVEILLANCE FOR EARLY-STAGE PROSTATE CANCER

peter carroll Information

University

Position

Professor of Urology

Citations(all)

106637

Citations(since 2020)

45018

Cited By

78534

hIndex(all)

159

hIndex(since 2020)

89

i10Index(all)

723

i10Index(since 2020)

417

Email

University Profile Page

University of California, San Francisco

Google Scholar

View Google Scholar Profile

peter carroll Skills & Research Interests

oncology

prostate cancer

Top articles of peter carroll

Title

Journal

Author(s)

Publication Date

Transcriptomic heterogeneity of expansile cribriform and other Gleason Pattern 4 prostate cancer subtypes

European Urology Oncology

Meera R Chappidi

Martin Sjöström

Nancy Y Greenland

Janet E Cowan

Avi S Baskin

...

2024/4/1

PD13-01 DETERMINING LONG-TERM PROSTATE CANCER OUTCOMES FOR ACTIVE SURVEILLANCE PATIENTS WITHOUT EARLY DISEASE PROGRESSION: WHEN TO SLOW OR STOP SURVEILLANCE

The Journal of Urology

Kevin Shee

Janet E Cowan

Lufan Wang

Samuel L Washington III

Katsuto Shinohara

...

2024/5

First-in-human evaluation of a prostate-specific membrane antigen–targeted near-infrared fluorescent small molecule for fluorescence-based identification of prostate cancer in …

European Urology Oncology

Hao G Nguyen

Nynke S van den Berg

Alexander L Antaris

Lingru Xue

Scott Greenberg

...

2024/2/1

Shed Trop2 drives prostate cancer progression and Trop2 is a novel tissue prognostic biomarker and a candidate urinary marker for prostate cancer

Cancer Research

Shiqin Liu

Sarah Hawley

Christian Kunder

En-Chi Hsu

Michelle Shen

...

2024/3/22

MP34-01 BASELINE PROSTATE-SPECIFIC ANTIGEN SCREENING VALUES IN TRANSGENDER WOMEN ON GENDER-AFFIRMING HORMONE THERAPY: A NATIONAL COHORT STUDY

The Journal of Urology

Farnoosh Nik-Ahd

Amanda de Hoedt

Christi Butler

Jennifer T Anger

Peter R Carroll

...

2024/5

The impact of genomic biomarkers on a clinical risk prediction model for upgrading/upstaging among men with favorable‐risk prostate cancer

Cancer

Avery E Braun

June M Chan

John Neuhaus

Janet E Cowan

Stacey A Kenfield

...

2024/1/27

RE: Clinical practice guidelines

Peter R Carroll

J Kellogg Parsons

2024/3/19

PD26-12 PERSISTENT NEED FOR SYSTEMATIC BIOPSY FOR THOSE ON ACTIVE SURVEILLANCE FOR EARLY-STAGE PROSTATE CANCER

The Journal of Urology

Mary Fakunle

Janet Cowan

Samuel Washington

Katsuto Shinohara

Hao Nguyen

...

2024/5

High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker

Scientific reports

Shiqin Liu

Sarah J Hawley

Christian A Kunder

En-Chi Hsu

Michelle Shen

...

2024/1/4

DOES GENOMIC RISK SCORE AT BIOPSY CORRELATE WITH FOCALITY OF DISEASE AT RADICAL PROSTATECTOMY: IMPLICATIONS FOR FOCAL THERAPY CANDIDATES

Urologic Oncology: Seminars and Original Investigations

Jenna Winebaum

Janet E Cowan

Henry Chen

Kevin Shee

Hao G Nguyen

...

2024/3/1

MP25-11 REAL-WORLD COMPARISON OF UTILITY OF PSMA PET IMAGING AND MRI IN EVALUATION OF LATERALITY OF PROSTATE CANCER

The Journal of Urology

Jenna G Winebaum

Janet E Cowan

Kevin Chang

Hao G Nguyen

Peter R Carroll

2024/5

Multi-institutional Development and External Validation of a Machine Learning Model for the Prediction of Distant Metastasis in Patients Treated by Salvage Radiotherapy for …

European urology focus

Ali Sabbagh

Derya Tilki

Jean Feng

Hartwig Huland

Markus Graefen

...

2024/1/1

Large cribriform glands (> 0.25 mm diameter) as a predictor of adverse pathology in men with Grade Group 2 prostate cancer

Histopathology

Nancy Y Greenland

Janet E Cowan

Bradley A Stohr

Jeffry P Simko

Peter R Carroll

...

2024/3

MP07-14 DEVELOPMENT OF A GENERATIVE ARTIFICIAL INTELLIGENCE DATA PIPELINE TO AUTOMATE THE CAPTURE OF UNSTRUCTURED MRI DATA FOR PROSTATE CANCER CARE

The Journal of Urology

Anobel Y Odisho

Andrew W Liu

William A Pace

Robert Krumm

Janet E Cowan

...

2024/5

Evaluation of URO17® to improve non-invasive detection of bladder cancer

Urologic Oncology: Seminars and Original Investigations

Sima P Porten

Elizabeth Y Wang

Poonam Vohra

Peter R Carroll

Sholeh Jahanfard

...

2024/6/1

Pre-surgical 68Ga-PSMA-11 PET for biochemical recurrence risk assessment: A surrogate of pelvic lymph node dissection? Follow-up analysis of a multicenter …

Loic Djaileb

Wesley Robert Armstrong

Daniel Thompson

Andrei Gafita

Andrea Farolfi

...

2024/2/1

Barriers and confidence among colorectal and prostate cancer survivors participating in two behavioral intervention studies

Supportive Care in Cancer

Vivian N Liu

Kyle B Zuniga

Alan Paciorek

Li Zhang

June M Chan

...

2023/8

Ten‐year work burden after prostate cancer treatment

Cancer Medicine

Samuel L Washington III

Peter E Lonergan

Janet E Cowan

Shoujun Zhao

Jeanette M Broering

...

2023/9

Effect of prostate brachytherapy case volume in the community setting on oncologic outcomes.

Kevin Chang

Lufan Wang

Janet E Cowan

Peter Carroll

Matthew R Cooperberg

2023/2/20

The impact of genomic biomarkers on a validated clinical risk prediction model for upgrading/upstaging among men with low-risk prostate cancer.

Avery Braun

Janet E Cowan

June M Chan

John Neuhaus

Peter Carroll

...

2023/2/20

See List of Professors in peter carroll University(University of California, San Francisco)